Vol.18 No.6

Review Article

Pro-apoptotic effect of nonsteroidal anti-inflammatory drugs on synovial fibroblasts

Authors

Natsuko Kusunoki1 , Ryuta Yamazaki2 , Shinichi Kawai1

  • Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, 6-11-1 Omori-Nishi, Ota-ku, Tokyo, 143-8541, Japan
  • Yakult Central Institute for Microbiological Research, Tokyo, Japan
Received:

24 March 2008

Accepted:

12 June 2008

Published online:

19 July 2008

Full Text

PDF　(member's only)

Abstract

Rheumatoid arthritis (RA) is a systemic inflammatory disease that mainly affects the articular synovial tissues. Although the etiology of RA has not yet been elucidated, physical and biochemical inhibition of synovial hyperplasia, which is the origin of articular destruction, may be an effective treatment for RA. Nonsteroidal anti-inflammatory drugs (NSAIDs) have long been used for the treatment of RA. The mechanism of action of NSAIDs generally involves the inhibition of cyclooxygenase (COX) at sites of inflammation. Thus, NSAIDs were not generally considered to have a so-called anti-rheumatic effect, including inhibition of progressive joint destruction and induction of remission. However, certain conventional NSAIDs and celecoxib, a selective COX-2 inhibitor, have been reported to inhibit synovial hyperplasia by inducing the apoptosis of human synovial fibroblasts. Therefore, it has been suggested that such NSAIDs may not only have an anti-inflammatory effect but also an anti-rheumatic effect. In this review, we summarize findings about the pro-apoptotic effect, in other words, anti-proliferative effect of NSAIDs on synovial fibroblasts from patients with RA.

Key words

Apoptosis - NSAIDs - Celecoxib - Synovial fibroblasts